Clinical Trial Update: Clinical Study of HER-096 in Healthy Volunteer Subjects and Patients With Parkinson's Disease [Phase 1]

View source ↗

Summary

This clinical trial update reports completion of a Phase 1 study of HER-096 in healthy volunteers and patients with Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• HER-096

Snippet

Sponsor: Herantis Pharma Plc. | Conditions: Parkinson Disease, Idiopathic | Phase 1 | Status: COMPLETED